1. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
   Dai Shimizu et al, 2017, Oncology Reports CrossRef
2. Bacterial Growth Inhibition Screen (BGIS) identifies a loss‐of‐function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin
   Haihong Guo et al, 2021, FEBS Letters CrossRef
3. Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
   Nicholas A. Pease et al, 2015, Journal of Oncology CrossRef
4. Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells
   Yao-Shun Yang et al, 2022, Oncogene CrossRef
5. Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
   Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
6. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis
   Jun Zhou et al, 2019, Bioscience Reports CrossRef
7. Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
   Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
8. Identification of ASF1A and HJURP by global H3–H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma
   Yongkang Liu et al, 2024, Scientific Reports CrossRef
9. DEK oncogene is overexpressed during melanoma progression
   Erica Riveiro‐Falkenbach et al, 2017, Pigment Cell & Melanoma Research CrossRef
10. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence
    Marie C. Matrka et al, 2018, PLOS Genetics CrossRef
11. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
    Yingai Zhang et al, 2019, Bioscience Reports CrossRef
12. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia
    Katherine E. Wilcher et al, 2023, Experimental Hematology CrossRef
13. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma
    Le Yu et al, 2016, Oncotarget CrossRef
14. DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
    Nicholas A. Pease et al, 2020, Cancers CrossRef
15. Bacterial Growth Inhibition Screen (BGIS): harnessing recombinant protein toxicity for rapid and unbiased interrogation of protein function
    Haihong Guo et al, 2021, FEBS Letters CrossRef
16. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners
    Yanan Zhang et al, 2016, Oncotarget CrossRef
17. Transcriptome Profile Reveals Genetic and Metabolic Mechanisms Related to Essential Fatty Acid Content of Intramuscular Longissimus thoracis in Nellore Cattle
    Gustavo Pimenta Schettini et al, 2022, Metabolites CrossRef
18. The unique DEK oncoprotein in women’s health: A potential novel biomarker
    Ana Cecília de Albuquerque Oliveira et al, 2018, Biomedicine & Pharmacotherapy CrossRef
19. Prognostic role of DEK in human solid tumors: a meta-analysis
    Gang Liu et al, 2017, Oncotarget CrossRef
20. MicroRNA-138 promotes neuroblastoma SH-SY5Y cell apoptosis by directly targeting DEK in Alzheimer’s disease cell model
    Jin Miao et al, 2020, BMC Neuroscience CrossRef
21. NUP214 in Leukemia: It’s More than Transport
    Adélia Mendes et al, 2019, Cells CrossRef
22. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer
    Jin Wang et al, 2021, Aging CrossRef
23. Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
    Allie N. Greene et al, 2022, Frontiers in Aging Neuroscience CrossRef
24. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/ p-Tyr216-GSK-3β/β-catenin axis
    Xiaoyang Xu et al, 2017, Oncology Reports CrossRef
25. Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma
    Ming-Xu Qiao et al, 2016, Oncology Reports CrossRef